INS and diabetes mellitus: Studies have demonstrated high accuracy of CGM devices in individuals with diabetes [1,2], supporting the safety of CGM systems for informing treatment decisions in adults with type 1 diabetes or individuals with type 2 diabetes who are on insulin [3,4,5].